Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor γ

被引:96
|
作者
Zhang, Lianying [1 ,2 ]
Ren, Xiao-Min [1 ]
Wan, Bin [1 ]
Guo, Liang-Hong [1 ]
机构
[1] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China
[2] Dezhou Univ, Coll Life Sci, Dezhou 253023, Peoples R China
基金
中国国家自然科学基金;
关键词
PAR gamma; Perfluorinated compounds; Ligand binding assay; Activation potency; Molecular docking; Structure-dependent; PPAR-GAMMA; PERFLUOROALKYL ACIDS; LIGAND-BINDING; FATTY-ACID; IN-VITRO; PERFLUOROOCTANOIC ACID; NUCLEAR RECEPTORS; ALPHA; EXPRESSION; MOUSE;
D O I
10.1016/j.taap.2014.06.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Perfluorinated compounds (PFCs) have been shown to disrupt lipid metabolism and even induce cancer in rodents through activation of peroxisome proliferator-activated receptors (PPARs). Lines of evidence showed that PPAR alpha was activated by PFCs. However, the information on the binding interactions between PPAR gamma and PFCs and subsequent alteration of PPAR gamma activity is still limited and sometimes inconsistent. In the present study, in vitro binding of 16 PFCs to human PPAR gamma ligand binding domain (hPPAR gamma-LBD) and their activity on the receptor in cells were investigated. The results showed that the binding affinity was strongly dependent on their carbon number and functional group. For the eleven perfluorinated carboxylic acids (PFCAs), the binding affinity increased with their carbon number from 4 to 11, and then decreased slightly. The binding affinity of the three perfluorinated sulfonic acids (PFSAs) was stronger than their PFCA counterparts. No binding was detected for the two fluorotelomer alcohols (FTOHs). Circular dichroim spectroscopy showed that PFC binding induced distinctive structural change of the receptor. In dual luciferase reporter assays using transiently transfected Hep G2 cells, PFCs acted as hPPAR gamma agonists, and their potency correlated with their binding affinity with hPPAR gamma-LBD. Molecular docking showed that PFCs with different chain length bind with the receptor in different geometry, which may contribute to their differences in binding affinity and transcriptional activity. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 50 条
  • [1] Structure-dependent activation of peroxisome proliferator-activated receptor gamma by organotin compounds
    Hiromori, Y.
    Nishikawa, J. I.
    Nagase, H.
    Nakanishi, T.
    TOXICOLOGY LETTERS, 2010, 196 : S306 - S306
  • [2] Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) γ by organotin compounds
    Hiromori, Youhei
    Nishikawa, Jun-ichi
    Yoshida, Ichiro
    Nagase, Hisamitsu
    Nakanishi, Tsuyoshi
    CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 180 (02) : 238 - 244
  • [3] Peroxisome proliferator-activated receptor γ activation in human breast cancer
    Yee, LD
    Sabourin, CLK
    Liu, L
    Li, HM
    Smith, PJ
    Seewaldt, V
    Kniss, DA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (05) : 967 - 973
  • [4] ENANTIOSELECTIVE ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR
    BOIE, Y
    ADAM, M
    RUSHMORE, TH
    KENNEDY, BP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (08) : 5530 - 5534
  • [5] Structure and physiological functions of the human peroxisome proliferator-activated receptor γ
    Zieleniak, Andrzej
    Wojcik, Marzena
    Wozniak, Lucyna A.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2008, 56 (05) : 331 - 345
  • [6] Structure and physiological functions of the human peroxisome proliferator-activated receptor γ
    Andrzej Zieleniak
    Marzena Wójcik
    Lucyna A. Woźniak
    Archivum Immunologiae et Therapiae Experimentalis, 2008, 56 : 331 - 345
  • [7] Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor
    Rau, O.
    Wurglics, M.
    Dingermann, Th.
    Abdel-Tawab, M.
    Schubert-Zsilavecz, M.
    PHARMAZIE, 2006, 61 (11): : 952 - 956
  • [8] Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone
    Sakamoto, J
    Kimura, H
    Moriyama, S
    Odaka, H
    Momose, Y
    Sugiyama, Y
    Sawada, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) : 704 - 711
  • [9] Binding and activity of bisphenol analogues to human peroxisome proliferator-activated receptor β/δ
    Li, Chuan-Hai
    Zhang, Dong-Hui
    Jiang, Li-Dan
    Qi, Yuan
    Guo, Liang-Hong
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2021, 226
  • [10] Activation and binding of peroxisome proliferator-activated receptor γ by synthetic cannabinoid ajulemic acid
    Liu, JL
    Li, H
    Burstein, SH
    Zurier, RB
    Chen, JD
    MOLECULAR PHARMACOLOGY, 2003, 63 (05) : 983 - 992